A small trial of Viagra for women with multiple sclerosis showed very limited benefit, only in the domain of lubrication. Let the giggling begin.
"PURPOSE: We assessed the tolerability, safety and efficacy of sildenafil (brand name: Viagra) for the treatment of women with sexual dysfunction secondary to multiple sclerosis, as well as the role of somatosensory evoked potential neurophysiological testing...
CONCLUSIONS: Sildenafil only appeared to produce limited benefit in certain individuals with female sexual dysfunction. Some measure of the extent of neurological deficit in these patients could be ascertained from the latency of tibial evoked potentials, which correlated with pudendal evoked potentials. However, it could not predict the extent of sexual dysfunction. Sildenafil is unlikely to help all patients with neurogenic female sexual dysfunction."
Click "read more" for the full abstract.